Daniel M. Geynisman - Publications, H-index & Citations

Daniel M. Geynisman

Fox Chase Cancer Center

39H指数

454论文数

5.5K被引数

收录论文 88

发表时间

Re: Perioperative Apalutamide in High-risk Localized Prostate Cancer 回复：围手术期阿帕鲁他胺在高风险局限性前列腺癌中的应用

European Urology

IF25.2

2026-10-03

PREAI

Gregory M. Hemenway; Daniel M. Geynisman

Prevalence of PD-L1-High Tumor Expression and Association with First-Line Treatment Outcomes in Patients with Metastatic Urothelial Carcinoma: Results from a Prospective Observational Cohort Study PD-L1高表达肿瘤的患病率及其与转移性尿路上皮癌患者一线治疗效果的关联：一项前瞻性观察队列研究的结果

Targeted Oncology

IF4

2026-10-02

OAAI

Petros Grivas; Piyush K. Agarwal; Hikmat Al-Ahmadie; Terence Friedlander; Daniel M. Geynisman; Yair Lotan; Alicia K. Morgans; Fernando J. Bianco; Sreenivasa Chandana; Bruno Fang; Michael Large; Joshua J. Meeks

Modeling Therapy Sequence for Advanced Cancer: A Microsimulation Approach Leveraging Electronic Health Record Data 基于电子健康记录数据的先进癌症治疗序列建模：一种微观模拟方法

Medical Decision Making

IF2.3

2026-09-29

PREAI

Elizabeth A. Handorf; J. Robert Beck; Daniel M. Geynisman

Feasibility and Characterization of Immune-related Pathologic Response Criteria in Renal Cell Carcinoma 肾细胞癌中免疫相关病理反应标准的可行性与表征

European Urology Oncology

IF9.3

2026-09-11

PREAI

Benjamin J. Croll; Hafiz A. Yahya; Jordan Fredette; Abigail Keller; Rainjade Chung; Shuanzeng Wei; Douglas Flieder; Fern Anari; Pooja Ghatalia; Elizabeth R. Plimack; Matthew R. Zibelman; Andres Correa; Alexander Kutikov; Randall Lee; Marc Smaldone; Robert Uzzo; Rosalia Viterbo; David Y.T. Chen; Daniel M. Geynisman

Updates at JNCCN JNCCN更新

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK

IF16.4

2025-12-01

PREAI

Geynisman, Daniel M.

Real-World Outcomes of Nivolumab Plus Ipilimumab Versus Pembrolizumab Plus Axitinib for First-Line Treatment of Advanced Renal Cell Carcinoma 纳武利尤单抗联合伊匹木单抗与帕博利珠单抗联合阿昔替尼用于晚期肾细胞癌一线治疗的真实世界结局比较

Clinical Genitourinary Cancer

IF2.7

2025-11-01

PREAI

Geynisman, Daniel M.; John, William S.; Miller, Taavy A.; Asgarisabet, Parisa; Falkenstein, Angelica; Savill, Kristin M. Zimmerman; Yin, Xin; del Tejo, Viviana; Guttenplan, Sarah B.; Rosenblatt, Lisa

Developing biomarkers and methods of risk stratification: Consensus statements from the International Kidney Cancer Symposium North America 2024 Think Tank 开发生物标志物和风险分层方法：国际肾癌研讨会北美2024年思辨研讨会的共识声明

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

IF2.3

2025-09-01

PREAI

Shapiro, Daniel D.; Abel, Edwin Jason; Albiges, Laurence; Battle, Dena; Berg, Stephanie A.; Campbell, Matthew T.; Cella, David; Coleman, Katie; Garmezy, Benjamin; Geynisman, Daniel M.; Hall, Tasha; Henske, Elizabeth P.; Jonasch, Eric; Karam, Jose A.; La Rosa, Salvatore; Leibovich, Bradley C.; Maranchie, Jodi K.; Master, Viraj A.; Maughan, Benjamin L.; Mcgregor, Bradley A.; Msaouel, Pavlos; Pal, Sumanta K.; Perez, Jose; Plimack, Elizabeth R.; Psutka, Sarah P.; Riaz, Irbaz B.; Rini, Brian I.; Shuch, Brian; Simon, Marie Celeste; Singer, Eric A.; Smith, Andrew; Staehler, Michael; Tang, Chad; Tannir, Nizar M.; Vaishampayan, Ulka; Voss, Martin H.; Zakharia, Yousef; Zhang, Qing; Zhang, Tian; Carlo, Maria I.

A Difficult Conversation 一次艰难的对话

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK

IF16.4

2025-04-01

PREAI

Geynisman, Daniel M.

Testicular Cancer, Version 2.2025 Featured Updates to the NCCN Guidelines 睾丸癌，版本 2.2025 NCCN 指南特色更新

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK

IF16.4

2025-04-01

PREAI

Gilligan, Timothy; Lin, Daniel W.; Adra, Nabil; Bagrodia, Aditya; Feldman, Darren R.; Yamoah, Kosj; Aggarwal, Rahul; Chandrasekar, Thenappan; Costa, Daniel; Drakaki, Alexandra; Eggener, Scott; Emamekhoo, Hamid; Geynisman, Daniel M.; Graham, Laura; Humphrey, Peter; Leuva, Harshraj; Levine, Ellis G.; Luckenbaugh, Amy; Maughan, Benjamin L.; Mcgregor, Bradley; Monk, Paul; Picus, Jool; Pierorazio, Phillip; Rais-Bahrami, Soroush; Reichert, Zachery; Rwigema, Jean-Claude; Saylor, Philip; Shah, Ankeet; Shah, Sumit; Singla, Nirmish; Sircar, Kanishka; Vanderweele, David; Zhumkhawala, Ali; Montgomery, Sarah; Sliker, Bailee

The Oncologist Outside the Exam Room 肿瘤科医生在诊室外

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK

IF16.4

2024-12-01

PREAI

Geynisman, Daniel m.

Racial differences in real-world outcomes of first-line therapies for advanced renal cell carcinoma

ONCOLOGIST

IF4.2

2024-12-01

OAAI

Geynisman, Daniel M.; John, William S.; Miller, Taavy A.; Asgarisabet, Parisa; Guttenplan, Sarah B.; Yin, Xin; Savill, Kristin M. Zimmerman; Mcallister, Lindsay; Rosenblatt, Lisa

Progress in Cancer 2024

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK

IF16.4

2024-11-01

PREAI

Geynisman, Daniel m.

Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial (Jun, 10.1038/s41591-024-03025-3, 2024)

NATURE MEDICINE

IF50

2024-07-02

PREAI

Li, Roger; Shah, Paras H.; Stewart, Tyler F.; Nam, Jong Kil; Bivalacqua, Trinity J.; Lamm, Donald L.; Uchio, Edward M.; Geynisman, Daniel M.; Jacob, Joseph M.; Meeks, Joshua J.; Dickstein, Rian; Pearce, Shane M.; Kang, Seok Ho; Jung, Seung Il; Kamat, Ashish M.; Burke, James M.; Keegan, Kirk A.; Steinberg, Gary D.

Artificial Intelligence and Oncology

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK

IF16.4

2024-07-01

PREAI

Geynisman, Daniel M.

Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial (Jun, 10.1038/s41591-024-03025-3, 2024)

NATURE MEDICINE

IF50

2024-06-18

OAAI

Li, Roger; Shah, Paras H.; Stewart, Tyler F.; Nam, Jong Kil; Bivalacqua, Trinity J.; Lamm, Donald L.; Uchio, Edward M.; Geynisman, Daniel M.; Jacob, Joseph M.; Meeks, Joshua J.; Dickstein, Rian; Pearce, Shane M.; Kang, Seok Ho; Il Jung, Seung; Kamat, Ashish M.; Burke, James M.; Keegan, Kirk A.; Steinberg, Gary D.

Oncolytic adenoviral therapy plus pembrolizumab in BCG-unresponsive non-muscle-invasive bladder cancer: the phase 2 CORE-001 trial

NATURE MEDICINE

IF50

2024-06-06

PREAI

ARV-766, A PROTAC ANDROGEN RECEPTOR (AR) DEGRADER, COMBINED WITH ABIRATERONE IN NOVEL HORMONAL AGENT (NHA)-NAïVE METASTATIC PROSTATE CANCER: PHASE 1 COHORT (PART C) OF A PHASE 1/2 STUDY

JOURNAL OF UROLOGY

IF6.8

2024-05-01

PREAI

Shore, Neal; Lang, Joshua M.; Geynisman, Daniel M.; Stewart, Tyler F.; Gao, Xin; Appleman, Leonard J.; Dreicer, Robert; Dorff, Tanya; Berghorn, Elmer; Duperret, Elizabeth; Lu, Haolan; Chan, Edward; Garmezy, Benjamin; Petrylak, Daniel P.

Renal cell carcinoma histologic subtypes exhibit distinct transcriptional profiles

JOURNAL OF CLINICAL INVESTIGATION

IF13.6

2024-04-23

OAAI

Barata, Pedro; Gulati, Shuchi; Elliott, Andrew; Hammers, Hans J.; Burgess, Earle; Gartrell, Benjamin A.; Darabi, Sourat; Bilen, Mehmet A.; Basu, Arnab; Geynisman, Daniel M.; Dawson, Nancy A.; Zibelman, Matthew R.; Zhang, Tian; Wei, Shuanzeng; Ryan, Charles J.; Heath, Elisabeth I.; Poorman, Kelsey A.; Nabhan, Chadi; McKay, Rana R.

Characteristics of patients with advanced renal cell carcinoma (aRCC) who received first-line (1L) nivolumab plus cabozantinib (NIVO plus CABO), pembrolizumab plus lenvatinib (PEM plus LEN), or nivolumab (NIVO) monotherapy in the real-world (RW) setting

CANCER RESEARCH

IF16.6

2024-03-22

PREAI

Zarrabi, Kevin K.; Miron, Benjamin; Yin, Xin; Rosenblatt, Lisa; Guttenplan, Sarah B.; John, William; Miller, Taavy A.; Asgarisabet, Parisa; Pathak, Prathamesh; Ahlquist, Monica; Gash, Yul Brian; Geynisman, Daniel M.

Molecular Characterization of TFE3-Rearranged Renal Cell Carcinoma: A Comparative Study With Papillary and Clear Cell Renal Cell Carcinomas TFE3-Rearranged肾细胞癌的分子特征: 与乳头状和透明细胞肾细胞癌的比较研究

MODERN PATHOLOGY

IF5.5

2024-02-01

PREAI

Weia, Shuanzeng; Krauseb, Harris B.; Geynismanc, Daniel M.; Elliottb, Andrew; Kutikovd, Alexander; Uzzod, Robert G.; Peia, Jianming; Baratae, Pedro; Carneirof, Benedito; Heathg, Elisabeth; Ryanh, Charles; Farrellb, Alex; Nabhanb, Chadi; Ali-Fehmii, Rouba; Naqashj, Abdul Rafeh; Arganik, Pedram; McKayl, Rana R.

研究方向